Evidence map›Paper›PMID 29755560›Full record

ArticleIranian journal of pharmaceutical research : IJPR2018

Anti-hypercholesterolemic Effect of Berbamine Isolated from

Bing Han, Shuming Kou, Kai He, Yulong Han, Yue Wang, Tao Huang, Xia Zhou, Yubo Xiao, Xuegang Li, Xiaoli Ye

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Antiviral Activity of Berbamine Against Influenza A Virus Infection.International journal of molecular sciences · 2025
    Article
  2. Review
  3. Antidiabetic activity ofFrontiers in pharmacology · 2023
    Article
  4. Review
  5. Review
  6. Frontiers in pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Bing HanSchool of Life Sciences, Southwest University, Chongqing, 400715, China.
Shuming KouSchool of Life Sciences, Southwest University, Chongqing, 400715, China.
Kai HeSchool of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Yulong HanSchool of Life Sciences, Southwest University, Chongqing, 400715, China.
Yue WangSchool of Life Sciences, Southwest University, Chongqing, 400715, China.
Tao HuangSchool of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Xia ZhouSchool of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Yubo XiaoSchool of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Xuegang LiSchool of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Xiaoli YeSchool of Life Sciences, Southwest University, Chongqing, 400715, China.
Southwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anti-hypercholesterolemic effect of berbamine (BBM) isolated from

Indexed as

BerbamineHypercholesterolemiaRhizoma CoptidisVascular lipid accumulationZebrafish

Identifiers

PMID29755560
PMCPMC5937099
OpenAlexW2772148007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.